4.7 Letter

Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions

Journal

LEUKEMIA
Volume 32, Issue 9, Pages 2085-2087

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41375-018-0214-x

Keywords

-

Funding

  1. Novartis
  2. BMS
  3. Incyte
  4. Pfizer

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available